← SynDRA
DIGOXIN
SynDRA canonical compound SYN0020295 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx/OTC |
|---|
| Primary target(s) | ATP1A1 |
|---|
| Mechanism of action | ATPase inhibitor |
|---|
| Indication | atrial fibrillation (AF) | congestive heart failure |
|---|
| Disease area | cardiology |
|---|
All known targets
- ATP1A1
- RORC
- ABCB1
- ATP1A1; ATP1A2; ATP1A3; ATP1B1; ATP1B2; ATP1B3
- ATP1A2
- ATP1A3
- ATP1A4
- ATP1B1
- ATP1B2
- ATP1B3
- FXYD2
- KCNH2
Mechanisms of action (all sources)
- ATPase inhibitor
- Inhibitor
- SLCO4C1 MODULATOR
- ATP1A1 INHIBITOR
- ATP1B1 INHIBITOR
- ATP1A3 INHIBITOR
- ATP1B2 INHIBITOR
- ATP1A2 INHIBITOR
- ATP1B3 INHIBITOR
- FXYD2 INHIBITOR
- ATP1A4 INHIBITOR
Drug classes
- Cardiac Glycoside
- Anti-Arrhythmia Agents
- Cardiotonic Agents
- Cardiovascular Agents
- Enzyme Inhibitors
- Protective Agents
ATC classes
- C01A · CARDIAC GLYCOSIDES
Cross-references
Synonyms
- cardiogoxin
- digoxine
- Digoxine
- Digoxina
- Digoxinum
- Dynamos
- Fargoxin
- Lanocardin
- Mapluxin
- Natigoxin
- Rougoxin
- Stillacor-
- Toloxin
- Vanoxin
- NSC-95100
- Digamex
- Digoxin pediatric
- Lanoxicaps
- Lanoxin
- Lanoxin pediatric
- Lanoxin-125
- Lanoxin-pg
- 12beta-Hydroxydigitoxin
- Digossina
- Digosin
- Lanicor
- Digacin
- Dilanacin
- CHEBI:4551
- MLS000069819
- Lanacordin
- Cardiogoxin
- Eudigox
- Davoxin
- SMR000059217
- Lenoxin
- Lanacrist
- Neo-Lanicor
Reported adverse events
- Thrombocytopenia
- Sinus bradycardia
- Ventricular arrhythmia
- Headache
- Nausea
- Abdominal pain
- Rash
- Vomiting
- Death
- Dizziness
- Tachycardia
Look up DIGOXIN in the interactive SynDRA portal →